Schedule III Rescheduling: Why Bank Access Could Be the Real Game-Changer for Cannabis MSOs
By Sheeba M. | May 4, 2026 Schedule III Rescheduling: Why Bank Access Could Be the Real Game-Changer for Cannabis MSOs TL;DR: As cannabis moves closer to Schedule III status, traditional banking access becomes unlocked—potentially saving MSOs $500M+ annually in working capital costs. This structural change could drive a 20-30% EPS uplift for the largest […]
Cannabis Beverage Market Set to Double: Which Companies Are Positioned to Win?
By Sheeba M. | May 4, 2026 Cannabis Beverage Market Set to Double: Which Companies Are Positioned to Win? TL;DR: Industry analysts project cannabis beverages will reach $14.4B by 2028 as consumer preference shifts toward infused drinks. Major players like Tilray and Cronos are scaling production, signaling strong margin expansion ahead. The cannabis beverage category […]
Consolidation Wave Accelerates: Why 2026 Could Be the Year of MSO Mega-Deals
By Sheeba M. | May 04, 2026 Consolidation Wave Accelerates: Why 2026 Could Be the Year of MSO Mega-Deals TL;DR: Falling valuations and rising debt loads are forcing smaller MSOs to the negotiating table, signaling a consolidation wave that could reshape the industry before rescheduling closes the M&A window. The cannabis M&A pipeline is heating […]
Cannabis MSOs Eye Federal Rescheduling as Tax Reform Opportunity Looms
By Sheeba M. | May 04, 2026 Cannabis MSOs Eye Federal Rescheduling as Tax Reform Opportunity Looms TL;DR: As federal rescheduling moves closer, major cannabis operators like Curaleaf and Greenrose are positioning for significant tax reform, potentially unlocking billions in deductions currently blocked under 280E. The cannabis industry is at an inflection point. After years […]
From the Village Green – May 4, 2026
Curated from social media posts and threads
Cannabis Supply Chain Optimization: The Hidden Margin Driver in Q2 2026
By Sheeba M. | May 03, 2026 Cannabis Supply Chain Optimization: The Hidden Margin Driver in Q2 2026 TL;DR: Transportation and logistics cost reductions are adding 150-200 bps to MSO gross margins in Q2 2026—Cresco Labs and Curaleaf could see outsized margin expansion when Q1 earnings land in May. The Freight Tailwind Nobody’s Talking About […]
MSO Debt Markets Show Signs of Life as Fed Rate Cuts Loom
By Sheeba M. | May 03, 2026 MSO Debt Markets Show Signs of Life as Fed Rate Cuts Loom TL;DR: Cannabis MSO debt yields have compressed 120 bps over 8 weeks as institutional capital flooded fixed-income markets—refinancing windows open in Q3 2026 for Curaleaf, Green Thumb, and Trulieve. The Capital Markets Reset The cannabis debt […]
California Cannabis Sales Hit Record $6.2B in 2025—What It Means for CURLF
By Sheeba M. | May 03, 2026 California Cannabis Sales Hit Record $6.2B in 2025—What It Means for CURLF TL;DR: California’s legal adult-use market surpassed $6.2B in 2025, with retail expansion accelerating—CURLF’s largest market could see same-store sales growth of 8-12% in H1 2026. California’s Department of Tax and Fee Administration released preliminary data showing […]
Cannabis Tax Reform: Budget Implications for CURLF & TCNNF
By Sheeba M. | May 03, 2026 Cannabis Tax Reform: Budget Implications for CURLF & TCNNF TL;DR: Federal tax reform bills targeting Section 280E could unlock $50M+ in tax relief for major cultivators like Curaleaf and Trulieve this fiscal year—a critical margin driver for Q2 earnings. The cannabis industry is watching Capitol Hill closely as […]
Hemp Delta-9 Market Explodes: $2B Opportunity or Regulatory Minefield?
By Sheeba M. | May 3, 2026 Hemp Delta-9 Market Explodes: $2B Opportunity or Regulatory Minefield? TL;DR: Hemp-derived delta-9 products are capturing mainstream retail shelf space, but DEA enforcement actions and state-level bans signal regulatory instability that could derail $2B+ projected revenue by 2027. The hemp-derived delta-9 market is growing faster than any regulator anticipated. […]